Darwin Global Management, Ltd. Quant / Systematic

CIK: 0001839209 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $543,280 (100.0% shares, 0.0% debt)

Holdings (12)

— ACCELERON PHARMA INC 63.4%
Value ($000) $344,200 Shares 2,000,000 Est. Cost $135.09 Unrealized —
NTLA INTELLIA THERAPEUTICS INC 18.6%
Value ($000) $100,884 Shares 752,024 Est. Cost $77.87 Unrealized +94.4%
BNTX BIONTECH SE 6.7%
Value ($000) $36,289 Shares 132,932 Est. Cost $272.99 Unrealized —
FATE FATE THERAPEUTICS INC 3.9%
Value ($000) $20,937 Shares 353,250 Est. Cost $72.67 Unrealized +7.9%
— INHIBRX INC 3.3%
Value ($000) $18,074 Shares 542,586 Est. Cost $31.09 Unrealized —
BBIO BRIDGEBIO PHARMA INC 2.2%
Value ($000) $11,891 Shares 253,692 Est. Cost $59.97 Unrealized -10.6%
IVVD ADAGIO THERAPEUTICS INC 0.7%
Value ($000) $3,655 Shares 86,528 Est. Cost $37.11 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value ($000) $2,869 Shares 159,393 Est. Cost $22.72 Unrealized -29.4%
VIR VIR BIOTECHNOLOGY INC 0.4%
Value ($000) $1,972 Shares 45,311 Est. Cost $43.29 Unrealized 0.0%
— VERVE THERAPEUTICS INC 0.2%
Value ($000) $1,288 Shares 27,397 Est. Cost $60.25 Unrealized —
FULC FULCRUM THERAPEUTICS INC 0.2%
Value ($000) $959 Shares 33,997 Est. Cost $18.95 Unrealized 0.0%
— AEROVATE THERAPEUTICS INC 0.0%
Value ($000) $262 Shares 12,484 Est. Cost $20.99 Unrealized —